Latest:
Managing Toxicities in Short- and Long-Term Treatment with ADCs
Vijayakrishna Gadi, MD, PhD, discusses short-term and long-term treatments with ADCs.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Edward P. Ambinder, MD
Latest:
More Progress Needed to Bring Oncology Practice Into the Digital Health Age
Much needs to be done to improve interoperability of medical data systems. However, standards and new systems are developing at a rapid pace, affording advantages and efficiencies where, previously, enormous impediments stood in the way.
Edward S. Kim, MD
Edward S. Kim, MD, is physician-in-chief of City of Hope Orange County, vice physician-in-chief of the City of Hope National Medical Center, and a professor in the Department of Medical Oncology & Therapeutics Research at City of Hope
Latest:
Ongoing Sigvotatug Vedotin Exploration Highlights Potential for Biomarker Advancement in NSCLC: With Edward S. Kim, MD, MBA; and Jyoti Malhotra, MD, MPH
Drs Kim and Malhotra discuss factors that make IB6 unique vs other NSCLC biomarkers and the study of sigvotatug vedotin in previously treated NSCLC.
Eileen M. O'Reilly, MD
Latest:
Dr. O'Reilly on Veliparib/Chemotherapy Triplet in Germline BRCA/PALB2+ Pancreatic Cancer
Eileen M. O’Reilly, MD, discusses the randomized phase II trial of gemcitabine and cisplatin versus gemcitabine and cisplatin and veliparib in patients with pancreas adenocarcinoma harboring a known germline BRCA or PALB2 mutation, which was presented at the 2020 Gastrointestinal Cancers Symposium.
Eileen M. O'Reilly, MD
Eileen M. O’Reilly, MD, is the Winthrop Rockefeller Endowed Chair of Medical Oncology and section head of hepatopancreaticobi at Memorial Sloan Kettering Cancer Center, as well as codirector of medical initiatives at the David M. Rubenstein Center for Pancreatic Cancer Research, in New York.
Latest:
Dr O’Reilly on the Potential of TTFields in Unresectable, Locally Advanced Pancreatic Cancer
Eileen M. O’Reilly, MD, discusses the potential of tumor treating fields for the treatment of patients with locally advanced pancreatic cancer.